How Accountable Care Is Transforming U.S. Healthcare

Health insurance companies are disclosing more information about just how big their bets are when it comes to converting payments to doctors and hospitals away from fee-for-service medicine to the new order of value-based medical care, which emphasizes transparency and quality

Jun 27, 2014 at 6:00PM

Health insurance companies are coaxing doctors and hospitals away from fee-for-service medicine at an unprecedented pace to new accountable care models they hope will tame health costs, improve quality and boost earnings.

Under the traditional fee-for-service model, doctors and hospitals are paid on a per treatment or procedure basis that generates volume and higher costs. The fee-for-service approach isn't always good for patients either if they are victims of excessive or unnecessary treatment.

By comparison, accountable arrangements pay doctors and hospitals to keep patients healthy and out of more expensive inpatient settings. Providers also have to achieve certain quality measures and outcomes for their patients in order to get extra money or bonuses. In health industry parlance, executives call it a push to "value-based" care.

But what supporters hope the value-based approach does for health plans and their bottom lines is wrench more expensive and potentially unneeded care from the U.S. health care system.

Health plans like Wellpoint (NYSE:ANTM), Aetna (NYSE:AET), Humana (NYSE:HUM) and UnitedHealth Group (NYSE:UNH) are setting aggressive goals and being more vocal to the financial community about the percentage of contracts they have in value-based or "accountable" arrangements.

Many insurers are expected to update Wall Street analysts and investors on their progress moving away from fee-for-service to accountable care in their second quarter earnings reports, which begin next month and should be watched closely.

Value-based arrangements come in many forms including "bundled payments" to a group of providers to treat a population of patients or via "patient-centered medical homes" and accountable care organizations (ACOs), which are umbrella entities that group providers together, rewarding doctors and hospitals for working together to improve quality and rein in costs.

"Our drive toward value-based arrangements has become our 'new normal', and today includes more than 110,000 contracted physicians and over 100 ACO-type organizations, compared to less than 50 ACOs a year ago," said Doug Wenners, senior vice president who handles provider contracts for Wellpoint, parent of several Blue Cross and Blue Shield plans that operate under the Anthem brand, in a statement to The Motley Fool.

Wellpoint said its ACO with Healthcare Partners physician group in California saved nearly $5 million in just six months.

Insurers say the value-based approaches are moving beyond the experimental stages.

"We're not just piloting this effort by investing in ACOs and patient-centered medical homes, we're applying the principles more broadly by investing in a new type of relationship with providers that rewards quality-driven, cost-effective care," Wenners said. "We hope to have 75 percent of primary care physicians in our networks participating in this population health model by 2016."

The biggest dollar figure disclosed thus far came last year when UnitedHealth Group said it would double to more than $50 billion the value of contracts it has with doctors and hospitals that are in accountable care arrangements of some kind.

UnitedHealth now says it expects its "accountable care" contracts to total $65 billion by the end of 2018 from $30 billion today. They will come in many forms.

"Most physicians are enthusiastic about accountable care payment models and would rather be paid for delivering value and better outcomes, and rewarded for spending more time with patients," UnitedHealth said in a statement. "Another reason for increased interest is the fact that we offer a variety of accountable care contracts. This enables us to customize payment models with care providers and meet them where they are in terms of readiness to move from fee-for-service to value-based contracts."

Aetna, too, is making in-roads with more than 1.7 million of the company's health plan enrollees getting medical care through value-based networks that include "36 accountable care organization collaborations, 114 patient-centered medical homes, 134 Medicare Advantage collaborations and 81 high-performance networks acquired in the Coventry transaction."

"Looking forward, we project that 20% to 25% of our medical costs will run through some form of value-based network contract in 2014 and are committed to increasing that participation percentage to 45% by 2017," Aetna said in a statement.

The federal government is already seeing results through the Medicare Shared Savings Program. Almost half of the ACOs that contracted with Medicare in 2012 had lower medical expenses than projected. They exceeded their quality benchmarks and therefore 29 ACOs generated shared savings of more than $125 million, according to the Centers for Medicare & Medicaid Services.

There are now more than 5 million Medicare beneficiaries receiving care through an ACO model, and insurance companies see that as only growing.

Humana spokesman Alex Kepnes said the insurer's "goal is to have 50 percent of our individual Medicare Advantage members taken care of by primary care physicians involved in full-risk accountable care arrangements by 2017."

Though U.S. health care is still largely a fee-for-service world, insurers see every contract as an opportunity to curb health spending, thereby hopefully boosting profits (and ultimately share price).

Leaked: This coming blockbuster will make every biotech jealous
The best biotech investors consistently reap gigantic profits by recognizing true potential earlier and more accurately than anyone else. Let me cut right to the chase. There is a product in development that will revolutionize not how we treat a common chronic illness, but potentially the entire health industry. Analysts are already licking their chops at the sales potential. In order to outsmart Wall Street and realize multi-bagger returns you will need The Motley Fool’s new free report on the dream-team responsible for this game-changing blockbuster. CLICK HERE NOW.

Bruce Japsen has no position in any stocks mentioned. The Motley Fool recommends UnitedHealth Group and WellPoint. The Motley Fool owns shares of WellPoint. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Money to your ears - A great FREE investing resource for you

The best way to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as “binge-worthy finance.”

Feb 1, 2016 at 5:03PM

Whether we're in the midst of earnings season or riding out the market's lulls, you want to know the best strategies for your money.

And you'll want to go beyond the hype of screaming TV personalities, fear-mongering ads, and "analysis" from people who might have your email address ... but no track record of success.

In short, you want a voice of reason you can count on.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich," rated The Motley Fool as the #1 place online to get smarter about investing.

And one of the easiest, most enjoyable, most valuable ways to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as "binge-worthy finance."

Whether you make it part of your daily commute or you save up and listen to a handful of episodes for your 50-mile bike rides or long soaks in a bubble bath (or both!), the podcasts make sense of your money.

And unlike so many who want to make the subjects of personal finance and investing complicated and scary, our podcasts are clear, insightful, and (yes, it's true) fun.

Our free suite of podcasts

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. The show is also heard weekly on dozens of radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable. Rule Breaker Investing and Answers are timeless, so it's worth going back to and listening from the very start; the other three are focused more on today's events, so listen to the most recent first.

All are available for free at

If you're looking for a friendly voice ... with great advice on how to make the most of your money ... from a business with a lengthy track record of success ... in clear, compelling language ... I encourage you to give a listen to our free podcasts.

Head to, give them a spin, and you can subscribe there (at iTunes, Stitcher, or our other partners) if you want to receive them regularly.

It's money to your ears.


Compare Brokers